Graeve L, Korolenko T A, Hemmann U, Weiergräber O, Dittrich E, Heinrich P C
Institut für Biochemie, Rheinisch-Westfälische Technische Hochschule Aachen, Germany.
FEBS Lett. 1996 Dec 9;399(1-2):131-4. doi: 10.1016/s0014-5793(96)01305-1.
In human body fluids a soluble form of the interleukin-6 receptor (sIL-6R) has been found which together with interleukin-6 (IL-6) acts agonistically on cells expressing the signal transducer gp130. The means by which the sIL-6R is removed from the circulation is unknown. Here, we show that a complex of 125I-labelled recombinant sIL-6R and IL-6 is internalized by MDCK cells stably transfected with gp130 and by human hepatoma cells HepG2 that endogenously express the IL-6R and gp130. We further show that most of the internalized sIL-6R is degraded within lysosomes. Our studies suggest that cells expressing gp130 are capable of endocytosing an IL-6/sIL-6R complex, thereby removing both from the circulation.
在人体体液中发现了一种可溶性白细胞介素-6受体(sIL-6R),它与白细胞介素-6(IL-6)共同对表达信号转导子gp130的细胞起激动作用。sIL-6R从循环中清除的方式尚不清楚。在此,我们表明,用gp130稳定转染的MDCK细胞以及内源性表达IL-6R和gp130的人肝癌细胞HepG2可内化125I标记的重组sIL-6R和IL-6的复合物。我们进一步表明,大部分内化的sIL-6R在溶酶体内被降解。我们的研究表明,表达gp130的细胞能够内吞IL-6/sIL-6R复合物,从而将两者从循环中清除。